RECALL ALERT: Zantac off the Market Because of its Link to Cancer

A recall order for popular heartburn remedy, Zantac, has been issued by the FDA.

On April 1, 2020, the U.S. Food and Drug Administration (FDA) issued a recall for Zantac because of its link to cancer.

The heartburn and stomach ulcer remedy, available in prescription and over-the-counter, is under investigation over a cancer-causing chemical found in the medication, N-nitrosodimethylamine (NDMA).

In its news release, the FDA announced that all Zantac medications should be immediately taken off the market because of its NDMA contamination. According to healthline.com, the FDA is “advising consumers taking [Zantac] to stop taking any tablets or liquid they currently have, dispose of them properly and not buy more…’”

Zantac has been associated with the following cancers:

  • Bladder Cancer
  • Colorectal Cancer
  • Esophageal Cancer
  • Kidney Cancer
  • Liver Cancer
  • Small Intestine Cancer
  • Stomach Cancer
  • Pancreatic Cancer

Most unsettling about this is that Zantac manufacturers may have known about NDMA’s presence in Zantac and its link to cancer, but did not say anything to its consumers. This means that the drug manufacturers cared more about their profits than the well-being of their consumers.

Drug manufacturers have a duty to warn consumers of the side effects a drug may cause. Their failure to do so may entitle you to compensation, including:

  • Past and future emotional pain and suffering
  • Recovery of past and future medical bills
  • Lost wages and earning capacity

The attorneys at Mase Mebane & Briggs are now working on the Zantac litigation. If you or a loved one has been taking Zantac prior to its recall and have since been diagnosed with cancer, you have the legal right to seek damages from those responsible. It is crucial that you have a proven Florida products liability attorney in your corner.

At Mase Mebane & Briggs, our Florida attorneys have decades of combined experience fighting for our clients in the courtroom and at the negotiating table. We know how courts and juries often look at these cases. Our results speak for themselves.